Literature DB >> 32193549

Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.

Paulina Andrade1,2, Parnal Narvekar1, Magelda Montoya1, Daniela Michlmayr1, Angel Balmaseda3, Josefina Coloma1, Eva Harris1.   

Abstract

BACKGROUND: The 4 antigenically distinct serotypes of dengue virus (DENV) share extensive homology with each other and with the closely related Zika flavivirus (ZIKV). The development of polyclonal memory B cells (MBCs) to the 4 DENV serotypes and ZIKV during DENV infection is not fully understood.
METHODS: In this study, we analyzed polyclonal MBCs at the single-cell level from peripheral blood mononuclear cells collected ~2 weeks or 6-7 months postprimary or postsecondary DENV infection from a pediatric hospital-based study in Nicaragua using a Multi-Color FluoroSpot assay.
RESULTS: Dengue virus elicits robust type-specific and cross-reactive MBC responses after primary and secondary DENV infection, with a significantly higher cross-reactive response in both. Reactivity to the infecting serotype dominated the total MBC response. Although the frequency and proportion of type-specific and cross-reactive MBCs were comparable between primary and secondary DENV infections, within the cross-reactive response, the breadth of MBC responses against different serotypes was greater after secondary DENV infection. Dengue virus infection also induced cross-reactive MBC responses recognizing ZIKV, particularly after secondary DENV infection.
CONCLUSIONS: Overall, our study sheds light on the polyclonal MBC response to DENV and ZIKV in naive and DENV-preimmune subjects, with important implications for natural infections and vaccine development.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Zika virus; cross-reactive; dengue virus; memory B cell; type-specific

Mesh:

Substances:

Year:  2020        PMID: 32193549      PMCID: PMC7377287          DOI: 10.1093/infdis/jiaa120

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.

Authors:  Paulina Andrade; Josefina Coloma; Eva Harris
Journal:  Methods Mol Biol       Date:  2018

Review 2.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

3.  Dengue epidemic in the stage of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes.

Authors:  R M Nogueira; M P Miagostovich; E Lampe; R W Souza; S M Zagne; H G Schatzmayr
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

4.  Structural basis of potent Zika-dengue virus antibody cross-neutralization.

Authors:  Giovanna Barba-Spaeth; Wanwisa Dejnirattisai; Alexander Rouvinski; Marie-Christine Vaney; Iris Medits; Arvind Sharma; Etienne Simon-Lorière; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Ahmed Haouz; Patrick England; Karin Stiasny; Juthathip Mongkolsapaya; Franz X Heinz; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2016-06-23       Impact factor: 49.962

5.  The 3.8 Å resolution cryo-EM structure of Zika virus.

Authors:  Devika Sirohi; Zhenguo Chen; Lei Sun; Thomas Klose; Theodore C Pierson; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2016-03-31       Impact factor: 47.728

6.  CD14+CD16+ monocytes are the main target of Zika virus infection in peripheral blood mononuclear cells in a paediatric study in Nicaragua.

Authors:  Daniela Michlmayr; Paulina Andrade; Karla Gonzalez; Angel Balmaseda; Eva Harris
Journal:  Nat Microbiol       Date:  2017-10-02       Impact factor: 17.745

7.  Evaluation of the traditional and revised WHO classifications of Dengue disease severity.

Authors:  Federico Narvaez; Gamaliel Gutierrez; Maria Angeles Pérez; Douglas Elizondo; Andrea Nuñez; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

8.  Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.

Authors:  Thavamalar Balakrishnan; Dennis B Bela-Ong; Ying Xiu Toh; Marie Flamand; Shamala Devi; Mickey B Koh; Martin L Hibberd; Eng Eong Ooi; Jenny G Low; Yee Sin Leo; Feng Gu; Katja Fink
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

9.  Dissecting the human serum antibody response to secondary dengue virus infections.

Authors:  Bhumi Patel; Patti Longo; Michael J Miley; Magelda Montoya; Eva Harris; Aravinda M de Silva
Journal:  PLoS Negl Trop Dis       Date:  2017-05-15

10.  Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.

Authors:  Ying Xiu Toh; Victor Gan; Thavamalar Balakrishnan; Roland Zuest; Michael Poidinger; Solomonraj Wilson; Ramapraba Appanna; Tun Linn Thein; Adrian Kheng-Yeow Ong; Lee Ching Ng; Yee Sin Leo; Katja Fink
Journal:  Front Immunol       Date:  2014-08-14       Impact factor: 7.561

View more
  6 in total

1.  Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.

Authors:  Leah C Katzelnick; Jose Victor Zambrana; Douglas Elizondo; Damaris Collado; Nadezna Garcia; Sonia Arguello; Juan Carlos Mercado; Tatiana Miranda; Oscarlett Ampie; Brenda Lopez Mercado; César Narvaez; Lionel Gresh; Raquel A Binder; Sergio Ojeda; Nery Sanchez; Miguel Plazaola; Krista Latta; Amy Schiller; Josefina Coloma; Fausto Bustos Carrillo; Federico Narvaez; M Elizabeth Halloran; Aubree Gordon; Guillermina Kuan; Angel Balmaseda; Eva Harris
Journal:  Sci Transl Med       Date:  2021-10-06       Impact factor: 17.956

Review 2.  Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.

Authors:  Leah C Katzelnick; Sandra Bos; Eva Harris
Journal:  Curr Opin Virol       Date:  2020-09-24       Impact factor: 7.090

Review 3.  Protection against dengue virus requires a sustained balance of antibody and T cell responses.

Authors:  Kristen M Valentine; Michael Croft; Sujan Shresta
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

Review 4.  Cross-Reactive Immunity among Five Medically Important Mosquito-Borne Flaviviruses Related to Human Diseases.

Authors:  Baohua Hou; Hui Chen; Na Gao; Jing An
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 5.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15

Review 6.  Dengue vaccine development by the year 2020: challenges and prospects.

Authors:  Annelies Wilder-Smith
Journal:  Curr Opin Virol       Date:  2020-10-18       Impact factor: 7.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.